San Diego-dependent Viking Therapeutics marked by itself as a serious competitor from the weight loss drug industry in February right after revealing promising info from a mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection and in March the company